Ecotoxicological risk assessment linked to the discharge by hospitals of bio-accumulative pharmaceuticals into aquatic media: The case of mitotane

Chemosphere

Volumn 93, Issue 10, 2013, Pages 2365-2372

  Aurélien, Brackers de Hugo ^a,c   Sylvie, Bony ^a,b   Alain, Devaux ^a,b   Jérôme, Guitton ^c   Yves, Perrodin ^a  

^a UNIVERSITÉ DE LYON   (France)

^b CEMAGREF   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Bio accumulation; Ecotoxicological risk assessment; Hospital wastewater; Mitotane; Pharmaceutical

Indexed keywords

CELL CULTURE; CHEMICAL CONTAMINATION; CYTOTOXICITY; DRUG PRODUCTS; HOSPITALS; POLLUTION; RISK PERCEPTION;

ECOTOXICOLOGICAL RISK ASSESSMENT; ECOTOXICOLOGICAL RISKS; ENVIRONMENTAL CONCENTRATION; HOSPITAL WASTEWATER; MITOTANE; PHARMACEUTICAL RESIDUES; POLLUTANT CONCENTRATION; THEORETICAL CALCULATIONS;

RISK ASSESSMENT;

BIOLOGICAL MARKER; DRUG RESIDUE; MITOTANE; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; WATER POLLUTANT;

DISCHARGE; DRUG; ECOTOXICOLOGY; GENOTOXICITY; POLLUTANT; RISK ASSESSMENT; SEWER NETWORK; WASTEWATER;

AQUATIC ENVIRONMENT; AQUATIC SPECIES; ARTICLE; BIOACCUMULATION; CALCULATION; CELL LINE; CYTOTOXICITY; ECOSYSTEM; ECOTOXICOLOGY; ENVIRONMENTAL EXPOSURE; FISH; FOOD CHAIN; FRANCE; GENOTOXICITY; HOSPITAL DISCHARGE; HOSPITAL WASTE; NONHUMAN; RISK ASSESSMENT; SEWER; WATER CONTAMINATION; ANIMAL; ENVIRONMENTAL MONITORING; METABOLISM; PHYSIOLOGY; TOXICITY; WATER POLLUTANT;

FRANCE; LYONS; RHONE; RHONE RIVER; RHONE-ALPES;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; AQUATIC ORGANISMS; ECOTOXICOLOGY; ENVIRONMENTAL MONITORING; FRANCE; MITOTANE; RISK ASSESSMENT; WATER POLLUTANTS, CHEMICAL;

EID: 84886946495     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2013.08.034     Document Type: Article

References (59)

1. Attivi D., Ajana I., Astier A., Demore B., Gibaud S. Development of microemulsion of mitotane for improvement of oral bioavailability. Drug Development and Industrial Pharmacy 2010, 36:421-427.
2. Boillot C., Perrodin Y. Joint-action ecotoxicity of binary mixtures of glutaraldehyde and surfactants used in hospitals: use of the toxicity index model and isoblogram representation. Ecotoxicology and Environmental Safety 2008, 71:252-259.
3. Boillot C., Bazin C., Tissot-Guerraz F., Droguet J., Perraud M., Cetre J.C., Trepo D., Perrodin Y. Daily physicochemical, microbiological and ecotoxicological fluctuations of a hospital effluent according to technical and care activities. Science of the Total Environment 2008, 403:113-129.
4. Bols N.C., Barlian A., Chirino-Trejo M., Caldwell S.J., Goegan P., Lee L.E.J. Development of a cell line from primary cultures of rainbow trout, Oncorhynchus mykiss (Walbaum), gills. Journal of Fish Diseases 1994, 17:601-611.
5. Brown K.D., Kulis J., Thomson B., Chapman T.H., Mawhinney D.B. Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico. Science of the Total Environment 2006, 366:772-783.
6. Bryan Ellis J., Yu W. Bacteriology of urban runoff: the combined sewer as a bacterial reactor and generator. Water Science and Technology 1995, 31:303-310.
7. Canadian Ministry of the Environment and Health (accessed 23.06.13). http://www.chemicalsubstanceschimiques.gc.ca/challenge-defi/batch-lot-2/index-fra.php.
8. Chandler G.T., Ferguson P.L., Klauber W., Washburn K. A critical body residue approach for predicting persistent bio-accumulative toxicant effects on reproduction and population dynamics of meiobenthic copepods. Environmental Toxicology and Chemistry 2012.
9. Coulibaly L., Naveau H., Agathos S.N. A tanks-in-series bioreactor to simulate macromolecule-laden wastewater pretreatment under sewer conditions by Aspergillus niger. Water Research 2002, 36:3941-3948.
10. ECB, 2003. Technical Guidance Document (TGD) in support of Commission Directive 93/67/EEC on Risk Assessment for new notified substances, Commission Regulation (EC) No 1488/94 on Risk Assessment for existing substances and Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market. European Chemical Bureau, Ispra (Italy), pp. 1044.
11. Emmanuel E., Keck G., Blanchard J.M., Vermande P., Perrodin Y. Toxicological effects of disinfections using sodium hypochlorite on aquatic organisms and its contribution to AOX formation in hospital wastewater. Environment International 2004, 30:891-900.
12. Emmanuel E., Hanna K., Bazin C., Keck G., Clement B., Perrodin Y. Fate of glutaraldehyde in hospital wastewater and combined effects of glutaraldehyde and surfactants on aquatic organisms. Environment International 2005, 31:399-406.
13. Environnement Canada, 2009. Profil de substance pour le Défi concernant le mitotane. http://www.chemicalsubstanceschimiques.gc.ca.
14. Escher B.I., Baumgartner R., Koller M., Treyer K., Judit L., McArdell C.S. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Research 2011, 45:75-92.
15. Ferrari B., Paxeus N., Giudice R.L., Pollio A., Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicology and Environmental Safety 2003, 55:359-370.
16. Ferrari B., Mons R., Vollat B., Fraysse B., Paxeus N., Lo Giudice R., Pollio A., Garric J. Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?. Environmental Toxicology and Chemistry 2004, 23:1344-1354.
17. Gobas F.A.P.C., Wilcockson J.B., Russell R.W., Haffner G.D. Mechanism of biomagnification in fish under laboratory and field conditions. Environmental Science and Technology 1999, 33:133-141.
18. Gros M., Petrović M., Ginebreda A., Barceló D. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environment International 2010, 36:15-26.
19. Grung M., Källqvist T., Sakshaug S., Skurtveit S., Thomas K.V. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. Ecotoxicology and Environmental Safety 2008, 71:328-340.
20. Halling-Sørensen B., Holten Lutzhoft H.-C., Andersen H.R., Ingerslev F. Environmental risk assessment of antibiotics: comparison of mecillinam, trimethoprim and ciprofloxacin. Journal of Antimicrobial Chemotherapy 2000, 46:53-58.
21. Han G.H., Hur H.G., Kim S.D. Ecotoxicological risk of pharmaceuticals from wastewater treatment plants in Korea: occurrence and toxicity to Daphnia magna. Environmental Toxicology and Chemistry 2006, 25:265-271.
22. Hightower L.E., Larry Renfro J. Recent applications of fish cell culture to biomedical research. Journal of Experimental Zoology 1998, 248:290-302.
23. Jean J., Perrodin Y., Pivot C., Trepo D., Perraud M., Droguet J., Tissot-Guerraz F., Locher F. Identification and prioritization of bioaccumulable pharmaceutical substances discharged in hospital effluents. Journal of Environmental Management 2012, 103:113-121.
24. Kelly B.C., Gobas F.A.P.C., McLachlan M.S. Intestinal absorption and biomagnification of organic contaminants in fish, wildlife, and humans. Environmental Toxicology and Chemistry 2009, 23:2324-2336.
25. Kienzler A., Tronchere X., Devaux A., Bony S. Assessment of RTG-W1, RTL-W1, and PLHC-1 fish cell lines for genotoxicity testing of environmental pollutants by means of a Fpg-modified comet assay. Toxicology In Vitro 2012, 26:500-510.
26. Kisanga E.R., Mellgren G., Lien E.A. Excretion of Hydroxylated metabolites of tamoxifen in human bile and urine. Anticancer Research 2005, 25:4487-4492.
27. Kortenkamp A., Altenburger R. Synergisms with mixtures of xenoestrogens: a reevaluation using the method of isoboles. Science of the Total Environment 1998, 221:59-73.
28. Kümmerer K. Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources - a review. Chemosphere 2001, 45:957-969.
29. Kümmerer K., Erbe T., Gartiser S., Brinker L. AOX - emissions from hospitals into municipal waste water. Chemosphere 1998, 36:2437-2445.
30. Lahti M., Oikari A. Pharmaceuticals in settleable particulate material in urban and non-urban waters. Chemosphere 2011, 85:826-831.
31. Landrum P.F., Lotufo G.R., Gossiaux D.C., Gedeon M.L., Lee J.H. Bioaccumulation and critical body residue of PAHs in the amphipod Diporeia spp additional evidence to support toxicity additivity for PAH mixtures. Chemosphere 2003, 51:481-489.
32. Langford K.H., Thomas K.V. Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works. Environment International 2009, 35:766-770.
33. Lewis M.A. The effects of mixtures and other environmental modifying factors on the toxicities of surfactants to freshwater and marine life. Water Research 1992, 26:1013-1023.
34. Lin A.Y.C., Yu T.H., Lin C.F. Pharmaceutical contamination in residential, industrial, and agricultural waste streams: Risk to aqueous environments in Taiwan. Chemosphere 2008, 74:131-141.
35. Löffler D., Ternes T.A. Determination of acidic pharmaceuticals, antibiotics and ivermectin in river sediment using liquid chromatography-tandem mass spectrometry. Journal of Chromatography A 2003, 1021:133-144.
36. Lopez-Serna R., Petrovic M., Barcelo D. Occurrence and distribution of multi-class pharmaceuticals and their actives metabolites and transformation products in the Ebro River Basin (NE Spain). Science of the Total Environment 2012, 440:280-289.
37. Lotufo G.R. Lethal and sublethal toxicity of sediment-associated fluoranthene to benthic copepods: application of the critical-body-residue approach. Aquatic Toxicology 1998, 44:17-30.
38. Matthijs E., Debaere G., Itrich N., Masscheleyn P., Rottiers A., Stalmans M., Federle T. The fate of detergent surfactants in sewer systems. Water Science and Technology 1995, 31:321-328.
39. Miège C., Choubert J., Ribeiro L., Eusèbe M., Coquery M. Fate of pharmaceuticals and personal care products in wastewater treatment plants - conception of a database and first results. Environmental Pollution 2009, 157:1721-1726.
40. Mullot J.-U., Karolak S., Fontova A., Levi Y. Modeling of hospital wastewater pollution by pharmaceuticals: first results of Mediflux study carried out in three French hospitals. Water Science and Technology: a Journal of the International Association on Water Pollution Research 2010, 62:2912-2919.
41. Ort C., Lawrence M.G., Reungoat J., Eaglesham G., Carter S., Keller J. Determining the fraction of pharmaceutical residues in wastewater originating from a hospital. Water Research 2010, 44:605-615.
42. Penttinen S., Malk V., Väisänen A., Penttinen O.P. Using the critical body residue approach to determine the acute toxicity of cadmium at varying levels of water hardness and dissolved organic carbon concentrations. Ecotoxicology and Environmental Safety 2011, 74:1151-1155.
43. Perrodin Y., Boillot C., Angerville R., Donguy G., Emmanuel E. Ecological risk assessment of urban and industrial systems: a review. Science of the Total Environment 2011, 409:5162-5176.
44. Rivière J.L. Évaluation du risque écologique des sols pollués 1998, Lavoisier, Paris, pp. 230.
45. Roberts P.H., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchement. Science of the Total Environment 2006, 356:143-153.
46. Santos J., Aparicio I., Alonso E. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environment International 2007, 33:596-601.
47. Santos J.L., Aparicio I., Alonso E. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environment International 2007, 33:596-601.
48. Sim W.-J., Lee J.-W., Lee E.-S., Shin S.-K., Hwang S.-R., Oh J.-E. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures. Chemosphere 2011, 82:179-186.
49. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research 1988, 175:184-191.
50. Sprehe M., Geißen S.-U., Vogelpohl A. Photochemical oxidation of iodized X-ray contrast media (XRC) in hospital wastewater. Water Science and Technology 2001, 44:317-323.
51. Tanaka N., Hvitved-Jacobsen T. Transformations of wastewater organic matter in sewers under changing aerobic/anaerobic conditions. Water Science and Technology 1998, 37:105-113.
52. Tauxe-Wuersch A., De Alencastro L.F., Grandjean D., Tarradellas J. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Research 2005, 39:1761-1772.
53. Thomas K.V., Dye C., Schlabach M., Langford K.H. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works. Journal of Environmental Monitoring 2007, 9:1410-1418.
54. US EPA Guidelines for Ecological Risk Assessment 1998, United States Environmental Protection Agency, Washington, pp. 188.
55. Verlicchi P., Galletti A., Petrovic M., Barceló D. Hospital effluents as a source of emerging pollutants: An overview of micropollutants and sustainable treatment options. Journal of Hydrology 2010, 389(3-4):416-428.
56. Verlicchi P., Al Aukidy M., Galletti A., Petrovic M., Barceló D. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Science of the Total Environment 2012, 430:109-118.
57. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment - a review. Science of the Total Environment 2012, 429:123-155.
58. Yang Y., Fu J., Peng H., Hou L., Liu M., Zhou J.L. Occurrence and phase distribution of selected pharmaceuticals in the Yangtze Estuary and its coastal zone. Journal of Hazardous Materials 2011, 190:588-596.
59. Zuccato E., Castiglioni S., Fanelli R., Reitano G., Bagnati R., Chiabrando C., Pomati F., Rossetti C., Calamari D. Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control. Environmental Science and Pollution Research 2006, 13:15-21.